This update is based on a press release statement from Invivyd, Inc. The company's stock has experienced significant volatility, with a 16.39% gain in the past week despite a 64.17% decline over six ...
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...
A big step forward in COVID-19 treatment and a breakthrough for a Florida-based nonprofit blood center serving the southeast. OneBlood just became the first blood center to get full FDA approval to ...
Invivyd (IVVD) announced the submission to the U.S. Food and Drug Administration, FDA, of an updated immunobridging analysis of pemivibart as ...
A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...
Kennedy filed a petition with the FDA in May 2021 demanding that officials rescind authorization for the shots and refrain ...
Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all COVID-19 vaccines in May 2021, just as vaccinated Americans ...
Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.
Robert F. Kennedy Jr. petitioned the FDA to revoke its authorization for the Covid-19 vaccine just six months after it was ...
The FDA is the leading science-based consumer protection agency in the world. Three former senior officials write about what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results